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Abstract  
Aims: Limited data exist regarding the objective evaluation of skin exsiccation caused 
by epidermal growth factor receptor (EGFR) inhibitors1. Objective indices were applied 
to evaluate the usefulness of a moisturizer against skin exsiccation associated with the 
use of of EGFR inhibitors for cancer patients. 
Patients and methods: Patients with either colorectal or head and neck cancer treated 
with either cetuximab or panitumumab were randomly assigned 1:2 to the prophylactic-
treatment arm, where participants received prophylactical moisturizer treatment 
(heparinoid preparation, Hirudoid®, Maruho, Osaka, Japan), or to the symptomatic-
treatment arm, where moisturizer was applied after the onset of cutaneous symptoms. 
Patients were observed for 6 weeks after the start of EGFR inhibitor administration. 
Results: A total of 15 patients were included and assessed: 6 in the prophylactic-treatment 
group and 9 in the symptomatic-treatment group. We evaluated the effect of EGFR 
inhibitors on the skin’s physiologic function. Administration of EGFR inhibitors resulted 
in a continued reduction in the moisture content of the horny layer and a decrease in 
cutaneous sebum levels. Skin observation revealed frequent development of an acneiform 
rash, and significantly higher exsiccation and exfoliation scores. EGFR inhibitor 
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administration was associated with a decrease in the horny layer moisture content and 
lower cutaneous sebum levels in the symptomatic-treatment group. In contrast, levels of 
both indicators were increased in the prophylactic-treatment group. Moreover, the EGFR-
Inhibitor-associated increase in exsiccation and exfoliation scores were minimized in the 
prophylactic-treatment group relative to the symptomatic-treatment group. 
Conclusion: Application of a moisturizer is effective against dry skin induced by 
administration of an EGFR inhibitor. 
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